Design and in vivo evaluation of an oral delivery system for insulin

Pharmaceutical Research

Volumn 17, Issue 12, 2000, Pages 1468-1474

  Marschutz M K ^a   Caliceti, P ^b   Bernkop Schnurch A ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

Controlled release; Enzyme inhibitors; Insulin degradation; Mucoadhesive polymers; Oral insulin delivery; Protective effect; Serine proteases; Thiolated polymers

Indexed keywords

BOWMAN BIRK INHIBITOR; CARBOXYMETHYLCELLULOSE; CARBOXYMETHYLCELLULOSE BOWMAN BIRK INHIBITOR; CARBOXYMETHYLCELLULOSE ELASTINAL; EXCIPIENT; INSULIN; POLYMER INHIBITOR CONJUGATE; SERINE PROTEINASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DIABETES MELLITUS; DRUG COATING; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG DOSAGE FORM; DRUG RELEASE; DRUG SCREENING; DRUG SYNTHESIS; ENZYME INHIBITION; GLUCOSE BLOOD LEVEL; INSULIN TREATMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; TABLET COMPRESSION;

ACRYLIC RESINS; ANIMALS; CARBOXYMETHYLCELLULOSE; CARBOXYPEPTIDASE B; CARBOXYPEPTIDASES; CARBOXYPEPTIDASES A; CYSTEINE; DIABETES MELLITUS, EXPERIMENTAL; DOSAGE FORMS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HYPOGLYCEMIC AGENTS; INSULIN; MICE; MICE, INBRED BALB C; PHARMACEUTIC AIDS; POLYMERS;

EID: 0034468106     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007696723125     Document Type: Article

References (23)

1. A case for oral insulin therapy in the prevention of diabetic micro- and macro-angiopathy
2. Recent developments in insulin delivery techniques: Current status and future potential
3. Differential effects of anionic, cationic, non-ionic and physiologic surfactants on the dissociation, chymotryptic degradation, and enteral absorption of insulin hexamers
4. Enhanced intestinal absorption of insulin in the presence of sodium 5-methoxysalicylate
5. 2EDTA, and sodium glycocholate on intestinal absorption of insulin
6. Absorption of protein via the intestinal wall
7. Promoting effect of the new chymotrypsin inhibitor KD-488 on the intestinal absorption of insulin in rats and dogs
8. Modified mucoadhesive polymers for the peroral administration of mainly elastase degradable therapeutic (poly)peptides
9. Synthesis, development and in vitro evaluation of drug delivery systems with protective effect against degradation by pepsin
10. Oral peptide drug delivery: Polymer-inhibitor conjugates protecting insulin from enzymatic degradation in vitro
11. Development of controlled drug release systems based on polymercysteine conjugates
12. Polymers with thiol groups: A new generation of mucoadhesive polymers?
13. Synthesis and characterization of mucoadhesive thiolated polymers
14. The use of inhibitory agents to overcome the enzymatic barrier to perorally administered therapeutic peptides and proteins
15. Chitosan capsules for colon-specific drug delivery: Improvement of insulin absorption from the rat colon
16. Enzymatic barriers for GI peptide and protein delivery
17. The development of stable protein formulations: A close look at protein aggregation, deamidation, and oxidation
18. Physical stabilization of insulin glycosylation
19. Receptor-binding region of insulin
20. Polycarbophil-cysteine conjugates as platforms for oral (poly)peptide delivery systems
21. Bioadhesion technologies for the delivery of peptide and protein drugs to the gastrointestinal tract
22. Enteral absorption of insulin in rats from mucoadhesive chitosan-coated liposomes
23. Effect of metabolic clearance rate and hepatic extraction of insulin on hepatic and peripheral contributions to hypoglycemia